Collectively, these observations illuminate that the resveratrol/β1-integrin/FAK/p65-NF-kB pathway may be an important underlying mechanism for resveratrol-promoted inhibition of CRC cell viability, growth, and proliferation in the TME. This evidence concerns the gene NFKB1 and colorectal carcinoma.